Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
|Articles|December 20, 2016
- December 2016 Heart Health
- Volume 82
- Issue 12
Can You Read These Rxs? (December 2016)
Can you you figure out what these prescriptions say?
Advertisement
Rx 1
Pharmacist Dinesh Patel of Rite-Aid in Merchantville, New Jersey, was impressed by how hard it was to read this prescription..
Can you read it?
SEE THE ANSWERS ON PAGE 2.ANSWERS
Rx 1: Contrave, take 2 PO BID #120
Rx 2: Celexa 20 mg 1 QD #30
Receive $50 Per Published Submission!
Send in your eye-straining, baffling prescriptions—now via e-mail and fax as well as regular mail! Submissions must include a clean photocopy or scanned image of the Rx; your institution’s name and location; your name and title; the correct name of the drug(s), strength, and dosing requirements; and your phone number. You can e-mail scanned Rxs to rmarotta@pharmacytimes.com; fax them to 609-257-0701; or mail them to Can You Read These Rxs?, Pharmacy Times, 666 Plainsboro Road, Suite 300, Plainsboro, NJ 08536.
Articles in this issue
almost 10 years ago
Recent Safety Data: Implications for Use of Proton Pump Inhibitorsalmost 10 years ago
Case Studies (December 2016)almost 10 years ago
Pet Peeves (December 2016)almost 10 years ago
US Generics Market Forecasted to Grow from 2016 to 2020almost 10 years ago
Generic Product News (December 2016)almost 10 years ago
Meeting Patients Where They Arealmost 10 years ago
Managing Workplace Changealmost 10 years ago
Comprehensive Addiction and Recovery Act of 2016almost 10 years ago
Termination of Employment Due to a Past Adverse Board ActionAdvertisement
Related to this article
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
3
Pneumonic Plague: What Pharmacists Need to Know About Treatment
4
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
5